National Research ( (NRC) ) has released its Q3 earnings. Here is a breakdown of the information National Research presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
National Research Corporation, operating as NRC Health, is a prominent player in the healthcare sector, specializing in healthcare experience improvement solutions. The company is known for its commitment to enhancing patient and employee experiences through insightful data and engagement strategies.
In the third quarter of 2025, NRC Health reported a notable increase in its Total Recurring Contract Value (TRCV), which rose by 8% year-over-year to $141.7 million. Additionally, the company saw a significant boost in cash flow from operations, which surged by 46% compared to the previous year, reaching $13.8 million.
Key financial highlights for the quarter include a total revenue of $34.6 million, marking a 2% increase from the previous quarter. The company achieved a GAAP net income of $4.1 million, which represents 12% of its revenue, and an adjusted net income of $5.0 million, accounting for 14% of its revenue. The adjusted EBITDA also saw an 11% year-over-year increase, amounting to $10.9 million and representing 31% of the revenue.
During the quarter, NRC Health repurchased 618,264 shares and increased its quarterly dividend by 33% to $0.16 per share, reflecting a strong commitment to returning value to shareholders. The company continues to focus on enhancing its financial performance and shareholder returns.
Looking ahead, NRC Health remains optimistic about its growth prospects, driven by its robust solutions that continue to gain trust from healthcare systems. The management is confident in maintaining its momentum through strategic partnerships and exceptional service delivery in the healthcare industry.